To provide direct evidence that the compounds being used actually are targeting the translation process in tumor cells in vivo; we analyzed the polyribosome content of Pten+/−Eμ-Myc tumors from mice treated with the elongation inhibitors. The gene discussed is MYC; the disease is neoplasm.